6-[[7-(3-fluoro-2-pyrimidin-2-ylbenzoyl)-7-azabicyclo[2.2.1]heptan-2-yl]amino]pyridine-3-carbonitrile
C23H19FN6O — CID 118882342
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[[7-(3-fluoro-2-pyrimidin-2-ylbenzoyl)-7-azabicyclo[2.2.1]heptan-2-yl]amino]pyridine-3-carbonitrile
6-[[7-(3-fluoro-2-pyrimidin-2-ylbenzoyl)-7-azabicyclo[2.2.1]heptan-2-yl]amino]pyridine-3-carbonitrile (PubChem CID 118882342) has the molecular formula C23H19FN6O and a molecular weight of 414.44 g/mol. Its IUPAC name is 6-[[7-(3-fluoro-2-pyrimidin-2-ylbenzoyl)-7-azabicyclo[2.2.1]heptan-2-yl]amino]pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | 6-[[7-(3-fluoro-2-pyrimidin-2-ylbenzoyl)-7-azabicyclo[2.2.1]heptan-2-yl]amino]pyridine-3-carbonitrile |
|---|---|
| PubChem CID | 118882342 |
| Molecular Formula | C23H19FN6O |
| Molecular Weight | 414.44 g/mol |
| Exact Mass | 414.16 |
| IUPAC Name | 6-[[7-(3-fluoro-2-pyrimidin-2-ylbenzoyl)-7-azabicyclo[2.2.1]heptan-2-yl]amino]pyridine-3-carbonitrile |
| SMILES | N#Cc1ccc(NC2CC3CCC2N3C(=O)c2cccc(F)c2-c2ncccn2)nc1 |
| InChI | InChI=1S/C23H19FN6O/c24-17-4-1-3-16(21(17)22-26-9-2-10-27-22)23(31)30-15-6-7-19(30)18(11-15)29-20-8-5-14(12-25)13-28-20/h1-5,8-10,13,15,18-19H,6-7,11H2,(H,28,29) |
| InChIKey | RFROCCVRHRNSNQ-UHFFFAOYSA-N |
| XLogP | 3.41 |
| TPSA | 94.80 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 414.44 |
| LogP ≤ 5 | 3.41 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118882342 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.